SCHEMBL9858703

SCHEMBL9858703

CCCCNS(=O)(=O)c1ccc(OC)c(OC)c1

nearest known ligand 0.89

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTT P42858 5/20 0.89
LMNA P02545 4/20 0.89
MAPK1 P28482 2/20 0.89
KMT2A Q03164 2/20 0.68
PDE4A P27815 1/20 0.66
PDE4B Q07343 1/20 0.66
PDE4C Q08493 1/20 0.66
PDE4D Q08499 1/20 0.66
NPSR1 Q6W5P4 1/20 0.61
ALDH1A1 P00352 5/20 0.60
TSHR P16473 2/20 0.60
HSD17B10 Q99714 1/20 0.60
POLB P06746 2/20 0.59
CYP1A2 P05177 1/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2C19 P33261 1/20 0.58
SMN1; SMN2 Q16637 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2791351 0.94 HTT (1.00) HTTLMNAMAPK1KMT2APDE4A
SCHEMBL2791185 0.94 HTT (1.00) HTTLMNAMAPK1KMT2APDE4A
SCHEMBL7420609 0.91 HTT (0.78) HTTLMNAMAPK1KMT2APDE4A
SCHEMBL4182162 0.89 KMT2A (0.77) HTTLMNAMAPK1KMT2APDE4A
SCHEMBL8777734 0.88 MAPK1 (0.71) HTTLMNAMAPK1KMT2APDE4A
SCHEMBL29306676 0.84 HTT (0.73) HTTLMNAMAPK1KMT2APDE4A
SCHEMBL4609361 0.84 ALDH1A1 (0.74) HTTLMNAMAPK1KMT2APDE4A
SCHEMBL5169194 0.83 KMT2A (0.69) HTTLMNAMAPK1KMT2APDE4A
SCHEMBL2676681 0.83 MAPK1 (0.73) HTTLMNAMAPK1KMT2APDE4A
SCHEMBL11573896 0.83 MAPK1 (0.80) HTTLMNAMAPK1KMT2APDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230125270-A1 RADIATION SENSITIVE COMPOSITION NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2023-04-27 US disclosed
US-20180181000-A1 RADIATION SENSITIVE COMPOSITION NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2018-06-28 US disclosed
EP-0412763-A2 Cephalosporins, processes for their preparation, pharmaceutical compositions containing them and intermediates therefor ZENECA LIMITED (GB) 1991-02-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180181000-A1 RADIATION SENSITIVE COMPOSITION RER1, RAD1, RAD51 HTT 4198/4885LMNA 247/4885MAPK1 2769/4885
US-20230125270-A1 RADIATION SENSITIVE COMPOSITION XRCC6, RAD50, XRCC5 HTT 4847/4885LMNA 1043/4885MAPK1 1253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.